2014 CRO Leadership Awards Winner
Categories Won:
-
Quality
-
Reliability
-
Regulatory
-
Productivity
-
Innovation
Drug Life Cycle Stages:
Research & Development: Clinical (Phase 1, Phase 2, Phase 3)
Main Service Areas:
Clinical
Services & Capabilities:
Chiltern is a fullservice global contract research organization offering services in: early phase, global clinical development, late phase, biometrics, medical & regulatory affairs, functional service provision, and contract staffing.
Therapeutic Areas:
CNS, infectious diseases & vaccines, oncology, ophthalmology, pediatrics, cardiorespiratory.
Jim EsinhartCEO“Chiltern is honored to be recognized three years running by distinguished members of the biopharmaceutical industry as a CRO leader in quality, reliability, innovation, productivity, and regulatory. Chiltern prides itself as a global, midtier development partner that offers flexibility, responsiveness, and quality delivery. On behalf of our Chiltern colleagues working around the world, it is a pleasure to accept this award.” |